Modulation of the Pulmonary Type 2 T-Cell Response toCryptococcus neoformansby Intratracheal Delivery of a Tumor Necrosis Factor Alpha-Expressing Adenoviral Vector
- 1 October 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (10) , 4951-4958
- https://doi.org/10.1128/iai.00176-07
Abstract
C57BL/6 mice develop an allergic bronchopulmonary mycosis following intratracheal inoculation ofCryptococcus neoformans24067. We determined that only low levels of tumor necrosis factor alpha (TNF-α) are produced in the lungs following infection. Thus, the objective of the present studies was to determine whether treatment with a TNF-α-expressing adenoviral vector (adenoviral vector with the murine TNF-α transgene under the control of the human cytomegalovirus promoter [AdTNFα]) could switch the type 2 (T2) T-cell response/T1 T-cell response balance toward the T1 T-cell response. AdTNFα induced an increase in TNF-α expression at days 3 and 7. At days 7 to 14, the number of cryptococcal lung CFU continued to increase in both untreated and control adenoviral vector (empty adenovirus type 5 backbone)-treated mice, but the number was ultimately 100-fold lower following AdTNFα treatment. AdTNFα markedly increased neutrophil and macrophage numbers, and pulmonary eosinophilia did not develop. CXCL1, CXCL2, and gamma interferon were also up-regulated, while eotaxin, interleukin-4 (IL-4), and IL-5 were down-regulated. AdTNFα treatment also increased the number of CD80+and CD40+cells and decreased the number of CD86+cells (CD11b+and CD11c+) in the lungs. Major histocompatibility complex class II levels on CD11b+cells were increased. Whole-lung expression of inducible nitric oxide synthase was increased, while YM2 expression and acidic mammalian chitinase expression were decreased. None of these effects were observed with the control (empty) adenoviral vector. Overall, these results support the hypothesis that early TNF-α expression promotes a shift in T-cell and macrophage polarization from T2/alternatively activated macrophages toward T1/classically activated macrophages, resulting in control of the fungal infection and prevention of the allergic response.Keywords
This publication has 26 references indexed in Scilit:
- Mannoproteins fromCryptococcus neoformansPromote Dendritic Cell Maturation and ActivationInfection and Immunity, 2005
- Transient Neutralization of Tumor Necrosis Factor Alpha Can Produce a Chronic Fungal Infection in an Immunocompetent Host: Potential Role of Immature Dendritic CellsInfection and Immunity, 2005
- Opsonic Requirements for Dendritic Cell-Mediated Responses toCryptococcus neoformansInfection and Immunity, 2005
- The chemokine system in diverse forms of macrophage activation and polarizationTrends in Immunology, 2004
- Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled AntigenThe Journal of Experimental Medicine, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Primary Dendritic Cells PhagocytoseCryptococcus neoformansvia Mannose Receptors and Fcγ Receptor II for Presentation to T LymphocytesInfection and Immunity, 2002
- Induction of Interleukin-12 and Gamma Interferon Requires Tumor Necrosis Factor Alpha for Protective T1-Cell-Mediated Immunity to PulmonaryCryptococcus neoformansInfectionInfection and Immunity, 2002
- Interdependency of Interleukin-10 and Interleukin-12 in Regulation of T-Cell Differentiation and Effector Function of Monocytes in Response to Stimulation withCryptococcus neoformansInfection and Immunity, 2001
- Intracellular Crystal Formation as a Mechanism of Cytotoxicity in Murine PulmonaryCryptococcus neoformansInfectionInfection and Immunity, 2001